Spinal Muscular Atrophy (SMA) Treatment Market Report

China Spinal Muscular Atrophy (SMA) Treatment Industry Market Research Report 2023-2029

  • POSTDATE：Oct 16, 2023
  • PAGES：151
  • REPORT CODE：GMM1860380
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Spinal muscular atrophy (SMA) refers to a group of inherited diseases that affects the functioning of muscles because of deterioration.

    North America dominates the global market for SMA treatment due to the high prevalence of SMA and increased adoption of SMA treatment options in the region.

    This report elaborates on the current development of the Spinal Muscular Atrophy (SMA) Treatment industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Ionis Pharmaceuticals

    • Pfizer

    • Novartis

    • Isis Pharmaceuticals

    • Scholor Rock

    • Roche

    By Type:

    • Type I Spinal Muscular Atrophy (SMA)

    • Type II Spinal Muscular Atrophy (SMA)

    • Type III Spinal Muscular Atrophy (SMA)

    By Application:

    • Others

    • Hospitals

    • Diagnostic Centers

    • Ambulatory Surgical Centers

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Spinal Muscular Atrophy (SMA) Treatment Market Overview 2018-2029

    • 1.1 China Spinal Muscular Atrophy (SMA) Treatment Industry Development Overview

    • 1.2 China Spinal Muscular Atrophy (SMA) Treatment Industry Development History

    • 1.3 China Spinal Muscular Atrophy (SMA) Treatment Industry Market Size (2018-2029)

    • 1.4 China Spinal Muscular Atrophy (SMA) Treatment Market Analysis by Type from Production Side

      • 1.4.1 China Spinal Muscular Atrophy (SMA) Treatment Production Volume, Production Value and Growth Rate of Type I Spinal Muscular Atrophy (SMA) (2018-2029)

      • 1.4.2 China Spinal Muscular Atrophy (SMA) Treatment Production Volume, Production Value and Growth Rate of Type II Spinal Muscular Atrophy (SMA) (2018-2029)

      • 1.4.3 China Spinal Muscular Atrophy (SMA) Treatment Production Volume, Production Value and Growth Rate of Type III Spinal Muscular Atrophy (SMA) (2018-2029)

    • 1.5 China Spinal Muscular Atrophy (SMA) Treatment Market Analysis by Application from Consumption End

      • 1.5.1 China Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.2 China Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

      • 1.5.3 China Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate of Diagnostic Centers (2018-2029)

      • 1.5.4 China Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate of Ambulatory Surgical Centers (2018-2029)

    • 1.6 China Spinal Muscular Atrophy (SMA) Treatment Market Analysis by Region

      • 1.6.1 North China Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate from 2018-2029

    Chapter 2 China Spinal Muscular Atrophy (SMA) Treatment Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Spinal Muscular Atrophy (SMA) Treatment Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Spinal Muscular Atrophy (SMA) Treatment Market Status and Competition Analysis in 2023

      • 2.2.3 China Spinal Muscular Atrophy (SMA) Treatment Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Spinal Muscular Atrophy (SMA) Treatment Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Spinal Muscular Atrophy (SMA) Treatment Industry Development

    Chapter 3 Spinal Muscular Atrophy (SMA) TreatmentIndustry Chain Analysis

    • 3.1 Spinal Muscular Atrophy (SMA) Treatment Industry Chain

    • 3.2 Spinal Muscular Atrophy (SMA) Treatment Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Spinal Muscular Atrophy (SMA) Treatment Market

    • 3.3 Spinal Muscular Atrophy (SMA) Treatment Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Spinal Muscular Atrophy (SMA) Treatment Market

    Chapter 4 China Spinal Muscular Atrophy (SMA) Treatment Market, by Type

    • 4.1 China Spinal Muscular Atrophy (SMA) Treatment Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Spinal Muscular Atrophy (SMA) Treatment Total Production Volume and Growth Rate from Production Side

    • 4.5 China Spinal Muscular Atrophy (SMA) Treatment Production Volume and Growth Rate, by Type

      • 4.5.1 China Spinal Muscular Atrophy (SMA) Treatment Production Volume and Growth Rate of Type I Spinal Muscular Atrophy (SMA)

      • 4.5.2 China Spinal Muscular Atrophy (SMA) Treatment Production Volume and Growth Rate of Type II Spinal Muscular Atrophy (SMA)

      • 4.5.3 China Spinal Muscular Atrophy (SMA) Treatment Production Volume and Growth Rate of Type III Spinal Muscular Atrophy (SMA)

    Chapter 5 China Spinal Muscular Atrophy (SMA) Treatment Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Spinal Muscular Atrophy (SMA) Treatment Total Market Size and Growth Rate from Consumption End

    • 5.5 China Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate, by Application

      • 5.5.1 China Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate of Others

      • 5.5.2 China Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate of Hospitals

      • 5.5.3 China Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate of Diagnostic Centers

      • 5.5.4 China Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate of Ambulatory Surgical Centers

    Chapter 6 China Spinal Muscular Atrophy (SMA) Treatment Market, by Region

    • 6.1 China Spinal Muscular Atrophy (SMA) Treatment Production Volume and Production Value, by Region

    • 6.2 China Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Sales Value, by Region

    Chapter 7 North China Spinal Muscular Atrophy (SMA) Treatment Market Analysis

    • 7.1 North China Spinal Muscular Atrophy (SMA) Treatment Market, by Type

    • 7.2 North China Spinal Muscular Atrophy (SMA) Treatment Market, by Application

    Chapter 8 Central China Spinal Muscular Atrophy (SMA) Treatment Market Analysis

    • 8.1 Central China Spinal Muscular Atrophy (SMA) Treatment Market, by Type

    • 8.2 Central China Spinal Muscular Atrophy (SMA) Treatment Market, by Application

    Chapter 9 South China Spinal Muscular Atrophy (SMA) Treatment Market Analysis

    • 9.1 South China Spinal Muscular Atrophy (SMA) Treatment Market, by Type

    • 9.2 South China Spinal Muscular Atrophy (SMA) Treatment Market, by Application

    Chapter 10 East China Spinal Muscular Atrophy (SMA) Treatment Market Analysis

    • 10.1 East China Spinal Muscular Atrophy (SMA) Treatment Market, by Type

    • 10.2 East China Spinal Muscular Atrophy (SMA) Treatment Market, by Application

    Chapter 11 Northeast China Spinal Muscular Atrophy (SMA) Treatment Market Analysis

    • 11.1 Northeast China Spinal Muscular Atrophy (SMA) Treatment Market, by Type

    • 11.2 Northeast China Spinal Muscular Atrophy (SMA) Treatment Market, by Application

    Chapter 12 Southwest China Spinal Muscular Atrophy (SMA) Treatment Market Analysis

    • 12.1 Southwest China Spinal Muscular Atrophy (SMA) Treatment Market, by Type

    • 12.2 Southwest China Spinal Muscular Atrophy (SMA) Treatment Market, by Application

    Chapter 13 Northwest China Spinal Muscular Atrophy (SMA) Treatment Market Analysis

    • 13.1 Northwest China Spinal Muscular Atrophy (SMA) Treatment Market, by Type

    • 13.2 Northwest China Spinal Muscular Atrophy (SMA) Treatment Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Ionis Pharmaceuticals

        • 14.1.1 Ionis Pharmaceuticals Company Profile

        • 14.1.2 Ionis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Pfizer

        • 14.2.1 Pfizer Company Profile

        • 14.2.2 Pfizer Spinal Muscular Atrophy (SMA) Treatment Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Novartis

        • 14.3.1 Novartis Company Profile

        • 14.3.2 Novartis Spinal Muscular Atrophy (SMA) Treatment Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Isis Pharmaceuticals

        • 14.4.1 Isis Pharmaceuticals Company Profile

        • 14.4.2 Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Scholor Rock

        • 14.5.1 Scholor Rock Company Profile

        • 14.5.2 Scholor Rock Spinal Muscular Atrophy (SMA) Treatment Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Roche

        • 14.6.1 Roche Company Profile

        • 14.6.2 Roche Spinal Muscular Atrophy (SMA) Treatment Market Performance

        • 14.6.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Spinal Muscular Atrophy (SMA) Treatment Industry Research Conclusions

    • 15.2 Spinal Muscular Atrophy (SMA) Treatment Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Industry Market Size (2018-2029)

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Production Volume, Production Value and Growth Rate of Type I Spinal Muscular Atrophy (SMA) (2018-2029)

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Production Volume, Production Value and Growth Rate of Type II Spinal Muscular Atrophy (SMA) (2018-2029)

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Production Volume, Production Value and Growth Rate of Type III Spinal Muscular Atrophy (SMA) (2018-2029)

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate of Diagnostic Centers (2018-2029)

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate of Ambulatory Surgical Centers (2018-2029)

    • Figure North China Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate from 2018-2029

    • Figure Central China Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate from 2018-2029

    • Figure South China Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate from 2018-2029

    • Figure East China Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate from 2018-2029

    • Figure Spinal Muscular Atrophy (SMA) Treatment Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Market Share by Type in 2018

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Market Share by Type in 2023

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Production Volume and Growth Rate of Type I Spinal Muscular Atrophy (SMA) (2018-2023)

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Production Volume and Growth Rate of Type II Spinal Muscular Atrophy (SMA) (2018-2023)

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Production Volume and Growth Rate of Type III Spinal Muscular Atrophy (SMA) (2018-2023)

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Market Share by Application in 2018

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Market Share by Application in 2023

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Total Market Size and Growth Rate from Consumption End

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate of Others (2018-2023)

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate of Hospitals (2018-2023)

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate of Diagnostic Centers (2018-2023)

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate of Ambulatory Surgical Centers (2018-2023)

    • Table China Spinal Muscular Atrophy (SMA) Treatment Production Volume by Region (2018-2023)

    • Table China Spinal Muscular Atrophy (SMA) Treatment Production Volume Share by Region (2018-2023)

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Production Volume Share by Region (2018-2023)

    • Table China Spinal Muscular Atrophy (SMA) Treatment Production Value by Region (2018-2023)

    • Table China Spinal Muscular Atrophy (SMA) Treatment Production Value Share by Region (2018-2023)

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Production Value Share by Region (2018-2023)

    • Table China Spinal Muscular Atrophy (SMA) Treatment Sales Volume by Region (2018-2023)

    • Table China Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share by Region (2018-2023)

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share by Region (2018-2023)

    • Table China Spinal Muscular Atrophy (SMA) Treatment Sales Value by Region (2018-2023)

    • Table China Spinal Muscular Atrophy (SMA) Treatment Sales Value Share by Region (2018-2023)

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Sales Value Share by Region (2018-2023)

    • Table North China Spinal Muscular Atrophy (SMA) Treatment Production Volume by Type (2018-2023)

    • Table North China Spinal Muscular Atrophy (SMA) Treatment Production Volume Share by Type (2018-2023)

    • Figure North China Spinal Muscular Atrophy (SMA) Treatment Production Volume Share by Type (2018-2023)

    • Table North China Spinal Muscular Atrophy (SMA) Treatment Sales Volume by Application (2018-2023)

    • Table North China Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share by Application (2018-2023)

    • Figure North China Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share by Application (2018-2023)

    • Table Central China Spinal Muscular Atrophy (SMA) Treatment Production Volume by Type (2018-2023)

    • Table Central China Spinal Muscular Atrophy (SMA) Treatment Production Volume Share by Type (2018-2023)

    • Figure Central China Spinal Muscular Atrophy (SMA) Treatment Production Volume Share by Type (2018-2023)

    • Table Central China Spinal Muscular Atrophy (SMA) Treatment Sales Volume by Application (2018-2023)

    • Table Central China Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share by Application (2018-2023)

    • Figure Central China Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share by Application (2018-2023)

    • Table South China Spinal Muscular Atrophy (SMA) Treatment Production Volume by Type (2018-2023)

    • Table South China Spinal Muscular Atrophy (SMA) Treatment Production Volume Share by Type (2018-2023)

    • Figure South China Spinal Muscular Atrophy (SMA) Treatment Production Volume Share by Type (2018-2023)

    • Table South China Spinal Muscular Atrophy (SMA) Treatment Sales Volume by Application (2018-2023)

    • Table South China Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share by Application (2018-2023)

    • Figure South China Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share by Application (2018-2023)

    • Table East China Spinal Muscular Atrophy (SMA) Treatment Production Volume by Type (2018-2023)

    • Table East China Spinal Muscular Atrophy (SMA) Treatment Production Volume Share by Type (2018-2023)

    • Figure East China Spinal Muscular Atrophy (SMA) Treatment Production Volume Share by Type (2018-2023)

    • Table East China Spinal Muscular Atrophy (SMA) Treatment Sales Volume by Application (2018-2023)

    • Table East China Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share by Application (2018-2023)

    • Figure East China Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share by Application (2018-2023)

    • Table Northeast China Spinal Muscular Atrophy (SMA) Treatment Production Volume by Type (2018-2023)

    • Table Northeast China Spinal Muscular Atrophy (SMA) Treatment Production Volume Share by Type (2018-2023)

    • Figure Northeast China Spinal Muscular Atrophy (SMA) Treatment Production Volume Share by Type (2018-2023)

    • Table Northeast China Spinal Muscular Atrophy (SMA) Treatment Sales Volume by Application (2018-2023)

    • Table Northeast China Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share by Application (2018-2023)

    • Table Southwest China Spinal Muscular Atrophy (SMA) Treatment Production Volume by Type (2018-2023)

    • Table Southwest China Spinal Muscular Atrophy (SMA) Treatment Production Volume Share by Type (2018-2023)

    • Figure Southwest China Spinal Muscular Atrophy (SMA) Treatment Production Volume Share by Type (2018-2023)

    • Table Southwest China Spinal Muscular Atrophy (SMA) Treatment Sales Volume by Application (2018-2023)

    • Table Southwest China Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share by Application (2018-2023)

    • Table Northwest China Spinal Muscular Atrophy (SMA) Treatment Production Volume by Type (2018-2023)

    • Table Northwest China Spinal Muscular Atrophy (SMA) Treatment Production Volume Share by Type (2018-2023)

    • Figure Northwest China Spinal Muscular Atrophy (SMA) Treatment Production Volume Share by Type (2018-2023)

    • Table Northwest China Spinal Muscular Atrophy (SMA) Treatment Sales Volume by Application (2018-2023)

    • Table Northwest China Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share by Application (2018-2023)

    • Table Ionis Pharmaceuticals Company Profile

    • Table Ionis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Spinal Muscular Atrophy (SMA) Treatment Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Spinal Muscular Atrophy (SMA) Treatment Revenue, Price and Gross (2018-2023)

    • Table Isis Pharmaceuticals Company Profile

    • Table Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Revenue, Price and Gross (2018-2023)

    • Table Scholor Rock Company Profile

    • Table Scholor Rock Spinal Muscular Atrophy (SMA) Treatment Revenue, Price and Gross (2018-2023)

    • Table Roche Company Profile

    • Table Roche Spinal Muscular Atrophy (SMA) Treatment Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US